Company Overview

Company name: MediJane Holdings (PINX: PLSI)
Description: Seller and distributor of cannabidiol products. The company engages in research and development of pharmaceutical products for the treatment of pain, cancer, psychological, gastrointestinal, autoimmune, neurological and sleep disorders.
Year founded: 2009
Parent company:
Industry: Healthcare | Group: Pharmaceuticals and Biotechnology | Code:
Employees: 3
City: Lafayette
State: Colorado
Country: United States
Region: Americas

Financial Highlights

Start up capital raised (USD Million): 0.10
Business status: Startup
Ownership: Publicly Held
Exchange: PINX
Ticker: PLSI
Revenue (USD Million): -0.14
Gross profit (USD Million):
Net income (USD Million) -11.76
Enterprise value:
Earnings before interest, tax, depreciation and amortization (EBITDA):
Fiscal period: TTM 2Q2016
Financing Status: The company was in talks to be acquired by Phoenix Life Sciences through a reverse merger, resulting in the combined entity trading on the PINX stock exchange under the ticker symbol MJMD on January 10, 2017. Subsequently the deal was cancelled.
Number of active investors:
Profile last updated: 06-Nov-2018
Last known valuation: 0.12
Last known valuation date: 08-Sep-2010